 - Have been treated with DMARDsDisease Modifying Antirheumatic Drugssystemic immunosuppressives during the 4 weeks, or 12 weeks for hydroxychloroquine, chloroquine, or leflunomide except when an adequate wash-out procedure for leflunomide was completed, prior to first administration of study drug. 